NovaBay Pharmaceuticals I... (NBY)
AMEX: NBY
· Real-Time Price · USD
0.55
-0.05 (-9.06%)
At close: Aug 15, 2025, 3:30 PM
0.62
13.76%
After-hours: Aug 15, 2025, 03:48 PM EDT
NovaBay Pharmaceuticals Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 8.47M | 430K | 776K | 751K | 1.82M | 3.13M | 3.47M | 4.41M | 3.75M | 5.36M | 3.87M | 3.93M | 5.64M | 7.5M | 9.03M | 10.29M | 10.51M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | 476K | 476K | 476K | 476K | 476K | 476K | 484K | 152K | 155K | 152K | 475K | 475K | 475K | 475K |
Other Long-Term Assets | 479K | 42.96M | 495K | n/a | 1K | 21K | 501K | 496K | 478K | 489K | 153K | 156K | 161K | 476K | n/a | n/a | 1K |
Receivables | n/a | 389K | 704K | 547K | 734K | 759K | 916K | 2.62M | 1.83M | 1.97M | 2.13M | 1.1M | 2.3M | 1.67M | 843K | 1.23M | 1.36M |
Inventory | n/a | 765K | 473K | 700K | 663K | 2.88M | 3.49M | 3.66M | 3.8M | 3.44M | 4.07M | 3.8M | 3.79M | 3.22M | 969K | 682K | 850K |
Other Current Assets | 10K | 158K | 116K | 94K | 96K | 81K | 72K | 197K | 132K | 159K | 109K | 151K | 228K | 144K | 117K | 97K | 131K |
Total Current Assets | 9.04M | 1.94M | 2.28M | 2.25M | 3.59M | 7.15M | 8.21M | 11.22M | 9.89M | 11.33M | 10.61M | 9.46M | 12.48M | 13.17M | 11.5M | 12.77M | 13.15M |
Property-Plant & Equipment | 355K | 1.01M | 1.1M | 1.2M | 1.29M | 1.38M | 1.62M | 1.74M | 1.86M | 1.95M | 2.15M | 2.38M | 2.52M | 604K | 266K | 356K | 450K |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | 2.51M | 2.55M | 2.59M | 2.63M | 9.46M | 9.55M | 9.64M | 9.73M | n/a | n/a | n/a |
Total Long-Term Assets | 834K | 43.97M | 1.6M | 1.67M | 1.77M | 1.88M | 4.64M | 4.79M | 4.93M | 5.07M | 11.76M | 12.09M | 12.32M | 10.81M | 741K | 831K | 926K |
Total Assets | 9.87M | 3.42M | 3.88M | 3.92M | 5.36M | 9.03M | 12.85M | 16.01M | 14.82M | 16.4M | 22.38M | 21.54M | 24.79M | 23.98M | 12.24M | 13.6M | 14.07M |
Account Payables | 800K | 623K | 396K | 1.24M | 1.12M | 1.13M | 947K | 1.48M | 1.15M | 1.08M | 1.1M | 930K | 1.56M | 1.04M | 1.35M | 208K | 833K |
Deferred Revenue | n/a | 488K | n/a | 773K | 745K | 946K | 1.04M | 1.82M | 1.86M | 1.81M | 1.7M | 1.47M | 1.91M | 1.29M | 579K | 943K | 862K |
Short-Term Debt | 84K | 565K | 51K | 1.08M | 1.01M | 1.63M | 1.75M | 1.66M | 466K | n/a | 445K | 470K | 465K | 305K | 195K | 298K | 396K |
Other Current Liabilities | 175K | 172K | 859K | 535K | 1.12M | 680K | 962K | 69K | 154K | n/a | -544K | -450K | -26K | 320K | 310K | 442K | 656K |
Total Current Liabilities | 3.07M | 2.84M | 1.98M | 3.61M | 3.92M | 4.28M | 4.57M | 6.07M | 4.42M | 4.26M | 3.71M | 3.66M | 4.78M | 3.44M | 2.87M | 2.39M | 3.08M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | 232K | 334K | n/a | n/a | n/a | n/a | 3.17M | 342K | 342K | 10.12M | n/a | n/a | n/a |
Total Long-Term Liabilities | 638K | 709K | 821K | 932K | 1.27M | 1.44M | 1.24M | 1.38M | 1.51M | 1.59M | 4.88M | 2.14M | 2.26M | 10.37M | 1K | 5K | 9K |
Total Liabilities | 3.71M | 3.55M | 2.81M | 4.54M | 5.2M | 5.72M | 5.82M | 7.45M | 5.93M | 5.84M | 8.59M | 5.8M | 7.05M | 13.81M | 2.88M | 2.39M | 3.09M |
Total Debt | 1.13M | 1.67M | 1.26M | 2.01M | 2.42M | 2.74M | 3M | 3.04M | 1.98M | 2.04M | 2.16M | 2.27M | 2.39M | 551K | 196K | 303K | 405K |
Common Stock | 58K | 49K | 49K | 13K | 320K | 112K | 65K | 673K | 652K | 652K | 650K | 535K | 514K | 478K | 450K | 447K | 418K |
Retained Earnings | -175.79M | -183.46M | -182.25M | -180.03M | -178.44M | -174.85M | -165.68M | -163.92M | -159.89M | -158.15M | -149.95M | -144.15M | -142M | -141.89M | -141.73M | -139.44M | -137.58M |
Comprehensive Income | n/a | n/a | n/a | -6K | -44K | -112K | -302K | -449K | -0.00 | n/a | n/a | -0.00 | -0.00 | -680K | 0.00 | n/a | n/a |
Shareholders Equity | 6.17M | -129K | 1.07M | -617K | 160K | 3.31M | 7.04M | 8.56M | 8.89M | 10.55M | 13.78M | 15.74M | 17.75M | 10.17M | 9.36M | 11.21M | 10.98M |
Total Investments | n/a | n/a | n/a | 476K | 476K | 476K | 476K | 476K | 476K | 484K | 152K | 155K | 152K | 475K | 475K | 475K | 475K |